the aid library

LIST OPTIONS

Filter

471

How are vaccines developed?

World Health Organization WHO (2021) C_WHO

This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a vaccine and the three clinical trial phases. Part three outlines the nex... more

Download (166)

View PDF (166)

Cum să faci ceea ce contează în perioade stresante: Un ghid ilustrat

World Health Organization WHO, Regional Office of Europe (2020) C_WHO

Cum să faci ceea ce contează în perioade stresante este un ghid al OMS de gestionare a stresului, pentru a face faţă mai ușor greutăţilor. Acest ghid ilustrat vine în sprijinul implementării recomandărilor OMS pentru gestionarea stresului.

Download (1301)

View PDF (2187)

Toma y envio de muestras de heces para estudios diagnosticos de V. cholerae

Organización Mundial de la Salud OMS (2010) C_WHO

Procedimientos para la identificación de Vibrio cholerae en el laboratorio de microbiología

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (2620)

View PDF (1825)

Vigilancia del virus Zika (ZIKV) en las Américas: Detección y diagnóstico por laboratorio

Organización Panamericana de la Salud Organización Mundial de la Salud, Oficina Regional para las Américas (2016) C_WHO

Este algoritmo está dirigido a aquellos laboratorios que cuentan con capacidad instalada para la detección (molecular, antigénica y/o serológica) de dengue (DENV), Zika (ZIKV) y chikungunya(CHIKV),y como parte del diagnóstico diferencial para Arbovirus. Para la manipulación de muestras sosp... more

Download (168)

View PDF (202)

Lineamientos técnicos para el usode la rueba de Lipoarabinomanano (LAM) como apoya diagnostico en patientes con VIH y sospecha de tuberculosis

Alabí Montoya, F.J.; C.G. Alvarenga Cardoza, K.M. Díaz de Naves Ministerio de Salud El Salvador (2021) C1

LAM test as a diagnostic aid in patients with HIV and suspected tuberculosis: technical guidelines

Download (130)

View PDF (142)

Procedimiento para el manejo de cadáveres de casos de COVID-19 - Documento técnico

Centro de Coordinación de Alertas y Emergencias Sanitarias Ministerio de sanidad - España (2020) C1

Download (578)

View PDF (700)

Recomendaciones para evitar la Leptospirosis

Ministerio de Salud Pública y Bienestar Social, DGVS Paraguay, et al. (2017) C1

Download (183)

View PDF (215)

Pertussis Vaccine-Preventable Diseases Surveillance Standards

World Health Organization WHO (2018) C_WHO

The objectives of pertussis surveillance are to:hmonitor disease burden and the impact of the pertussis vaccination programme, with a special focus on understanding the morbidity and mortality in children < 5 years of agehgenerate data to inform vaccine schedule and delivery strategy decisions to op... more

Download (620)

View PDF (1014)

Naijiria: NCHOPUTA GBASARA AHUIKE UMUNWANYI, UMUNWOKE NA UMUAKA

The DHS Program, Rockville (2014) C1

Download (523)

View PDF (971)

Dengue manejo de casos en Adultos

Ministerio de Salud Pública y Bienestar Social Paraguay: Organización Panamericana de la Salud, et al. (2012) C_WHO

External Link

How do vaccines work?

World Health Organization WHO (2021) C_WHO

This article is part four in a series of explainers on vaccine development and distribution Available in different languages

Download (420)

View PDF (686)

Nchoputa Gbasara Ahuike Umunwanyi, Umunwoke na Umuaka: Mpaghara Owuwa Anyanwu (South East)

National Population Commission (NPC), Abuja; The DHS Program, Rockville (2014) C1

Download (182)

View PDF (334)

Integration of HIV testing and linkage in family planning and contraception services: implementation brief

World Health Organisation (WHO) (2021) C_WHO

This implementation brief addresses integration of HIV testing services into family planning (FP) services. It is intended as a practical resource for national health programmes seeking to introduce or scale up HIV testing and linkage to HIV prevention, sexually transmitted infection, and antiretrov... more

External Link

Framework for Environmental and Social Management

Food and Agriculture Organization of the United Nations FAO (2023) CC

The Food and Agriculture Organization of the United Nations (FAO) launched a new Framework for Environmental and Social Management (FESM) to ensure that both people and the environment are protected from any potential impacts of FAO programmes and projects. “This Framework ensures that our proj... more

Download (997)

View PDF (1818)

Virus del Ébola

International SOS (2014)

Download (141)

View PDF (194)

Manual técnico de referencia para la higiene de la manos

World Health Organization WHO (2009) C_WHO

Las infecciones relacionadas con la atención sanitaria (IRAS) suponen una tremenda carga de enfermedad y tienen un importante impacto económico en los pacientes y los sistemas sanitarios de todo el mundo. Pero una buena higiene de las manos, la sencilla tarea de limpiarse las manos en el m... more

Download (168)

View PDF (195)

Enhancing the Role of Community Health Nursing for Universal Health Coverage

World Health Organisation (WHO) (2017) C_WHO

Community health nurses have the potential to make significant contributions to meet the health care needs of various population groups in a variety of community settings. In order to assess the extent to which CHNs are achieving this potential, WHO conducted a study between 2010 and 2014 that exami... more

Download (317)

View PDF (308)

Nature, biodiversity and health: an overview of interconnections

World Health Organization. Regional Office for Europe (2021) C_WHO

Urbanization, land use, global trade and industrialization have led to profound and negative impacts on nature, biodiversity and ecosystems across the world. The ongoing depletion of natural resources not only afects environmental conditions but also has an enormous impact on the well-being and secu... more

Download (219)

View PDF (147)

Categorización de riesgo y manejo del personal de salud potencialmente expuesto a COVID 19

Paraguay Ministerio de Salud Pública y Bienestar Ministerio de Salud Publica Paraguay (2020) C2

El objetivo del documento es orientar la categorización de riesgo, monitoreo y decisiones a ser tomadas para el personal de salud con potencial exposición a COVID-19. Esta guía puede ser modificada de acuerdo al dinamismo de la situación epidemiológica. Este documento debe leerse en conjunto co... more